Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.6%

1 terminated out of 28 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (9)
P 1 (4)
P 2 (10)
P 3 (2)

Trial Status

Completed9
Active Not Recruiting8
Recruiting8
Suspended1
Withdrawn1
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT06671912Phase 3SuspendedPrimary

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

NCT06008158Phase 2Active Not RecruitingPrimary

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

NCT06538389Phase 2RecruitingPrimary

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

NCT05379153Phase 3RecruitingPrimary

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

NCT07443943Phase 2RecruitingPrimary

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

NCT04993313Not ApplicableActive Not RecruitingPrimary

Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study

NCT06401889RecruitingPrimary

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

NCT03012399Not ApplicableActive Not RecruitingPrimary

Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery

NCT04906200Not ApplicableActive Not RecruitingPrimary

Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors

NCT04959474Not ApplicableRecruitingPrimary

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

NCT04871516Not ApplicableActive Not RecruitingPrimary

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

NCT04754412Not ApplicableActive Not RecruitingPrimary

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

NCT04999826CompletedPrimary

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

NCT06297265Not ApplicableRecruitingPrimary

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

NCT06153836Phase 2RecruitingPrimary

Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction

NCT06106282CompletedPrimary

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

NCT04862585Phase 2CompletedPrimary

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

NCT07044310Phase 2RecruitingPrimary

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

NCT04290897Phase 2CompletedPrimary

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors

NCT04549571Not ApplicableActive Not RecruitingPrimary

Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions

Scroll to load more

Research Network

Activity Timeline